← Back
Research and new methods

Universal CAR-T: ready-made donor cells

Universal (allogeneic) CAR-T is made in advance from a healthy donor's T cells and can be used without waiting several weeks. This approach is still mostly in trials.

Last updated: ~1 min read
A human T cell in false colour under a scanning electron microscope
Figure 1.A donor T cell — the material for universal CAR-T

01Short answer

Standard CAR-T is made individually from each patient's own cells. In the universal version, donor cells are changed by gene editing so that they do not attack the patient's body (GVHD risk) and are not quickly rejected by the patient's immune system. The advantages are speed and availability; the challenges are short survival of the cells in the body and safety. Results so far are early.

02Simple explanation

Donor cells.

Ready in advance.

Gene editing.

Still in trials.

03Scientific explanation

NCI: researchers are studying “off-the-shelf” CAR-T products made from donor cells.

NCI: new treatments are tested step by step, from the laboratory to clinical trials; only those proven safe and beneficial become standard care.

04What happens in the body?

Why it is needed

Some patients cannot wait for manufacturing, or their own T cells are weakened.

A hiding shield
Figure 2.A hiding shield — Universal CAR-T: ready-made donor cells

Challenges

Rejection, GVHD and short persistence.

A cell library
Figure 3.A cell library — Universal CAR-T: ready-made donor cells

How to read the news

Research news brings hope, but not every advance suits everyone. Look at who it was tested in, at what phase and in how many people.

Talk to your doctor

Show your doctor what you have read; they will explain how it relates to your diagnosis and treatment. Do not change your treatment on your own.

05From research news to a conversation: four steps

Read, check, ask, decide together.

Read — From a trusted source.1ReadFrom a trusted source.
Check — Phase, participants, result.2CheckPhase, participants, result.
Ask — Show your doctor.3AskShow your doctor.
Decide — Together, without rushing.4DecideTogether, without rushing.
SourceA trusted site.
DoctorA personal explanation.
SafetyNot changing treatment yourself.

06Key points at a glance

TopicIn brief
Why it is neededSome patients cannot wait for manufacturing, or their own T cells are weakened.
ChallengesRejection, GVHD and short persistence.
How to read the newsResearch news brings hope, but not every advance suits everyone. Look at who it was tested in, at what phase and in how many people.
Talk to your doctorShow your doctor what you have read; they will explain how it relates to your diagnosis and treatment. Do not change your treatment on your own.

07Key terms

Allogeneic
Taken from another person.
Gene editing
Precise changes to DNA.
Clinical trial
Testing a new treatment with volunteers.
Evidence
A result confirmed by reliable research.

08Key points

  • Learn.
  • Ask your doctor.
  • Write it down.
  • Check the source.
  • Talk to your doctor.

09Frequently asked questions

Is universal CAR-T available yet?

Mostly in clinical trials.

Is it better than standard CAR-T?

Not yet known; comparison studies are needed.

Is this advance right for me?

Only your treating doctor can say, based on your diagnosis, stage and condition.

10Questions for your doctor

Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.

  1. Is universal CAR-T available yet?

  2. Is it better than standard CAR-T?

  3. Is this advance right for me?

My questions

12Sources

  1. National Cancer Institute. CAR T Cells: Engineering Immune Cells to Treat Cancer
  2. National Cancer Institute. Immunotherapy to Treat Cancer
  3. National Cancer Institute. What Are Clinical Trials?
  4. National Cancer Institute. Phases of Clinical Trials
  5. National Cancer Institute. Using Trusted Resources
  6. National Cancer Institute. NCI Dictionary of Cancer Terms: somatic mutation
  7. National Cancer Institute. NCI Dictionary of Cancer Terms: targeted therapy
  8. National Cancer Institute. NCI Dictionary of Cancer Terms: biomarker
  9. National Cancer Institute. NCI Dictionary of Cancer Terms: precision medicine
  10. National Cancer Institute. NCI Dictionary of Cancer Terms: genomic profiling
Medical disclaimerThis information is for educational purposes only and does not replace medical advice.
Last updated: ← Back to the list

Open the interactive site →